It is understood that apoptotic endothelial-derived MVs (EMVs) such as CD144+ can be a predictor of, and correlate with, coronary artery disease (CAD), and are considered to be a promising biomarker of thromboembolic conditions [39,40]. The gene discussed is CDH5; the disease is coronary artery disorder.